These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 17687515
1. MPTP-induced central dopamine depletion exacerbates experimental autoimmune encephalomyelitis (EAE) in C57BL mice. Bałkowiec-Iskra E, Kurkowska-Jastrzebska I, Joniec I, Ciesielska A, Muszynska A, Przybyłkowski A, Członkowska A, Członkowski A. Inflamm Res; 2007 Aug; 56(8):311-7. PubMed ID: 17687515 [Abstract] [Full Text] [Related]
2. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization. Shen YQ, Hebert G, Lin LY, Luo YL, Moze E, Li KS, Neveu PJ. J Neuroimmunol; 2005 Jan; 158(1-2):14-25. PubMed ID: 15589033 [Abstract] [Full Text] [Related]
3. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis. Wheeler RD, Zehntner SP, Kelly LM, Bourbonnière L, Owens T. Immunology; 2006 Aug; 118(4):527-38. PubMed ID: 16780563 [Abstract] [Full Text] [Related]
4. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. Zheng X, Hu X, Zhou G, Lu Z, Qiu W, Bao J, Dai Y. J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251 [Abstract] [Full Text] [Related]
5. Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease. Kurkowska-Jastrzebska I, Bałkowiec-Iskra E, Ciesielska A, Joniec I, Cudna A, Zaremba MM, Członkowski A, Członkowska A. Int Immunopharmacol; 2009 Jun; 9(6):781-91. PubMed ID: 19286483 [Abstract] [Full Text] [Related]
6. The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice. Allameh A, Maleklou N, Zargari M, Sanati MH. Neurosci Lett; 2008 Jul 04; 439(1):111-5. PubMed ID: 18501514 [Abstract] [Full Text] [Related]
8. Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-Bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitis. Moore CS, Earl N, Frenette R, Styhler A, Mancini JA, Nicholson DW, Hebb AL, Owens T, Robertson GS. J Pharmacol Exp Ther; 2006 Oct 04; 319(1):63-72. PubMed ID: 16809479 [Abstract] [Full Text] [Related]
9. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. Morini M, Roccatagliata L, Dell'Eva R, Pedemonte E, Furlan R, Minghelli S, Giunti D, Pfeffer U, Marchese M, Noonan D, Mancardi G, Albini A, Uccelli A. J Neuroimmunol; 2004 Mar 04; 148(1-2):146-53. PubMed ID: 14975595 [Abstract] [Full Text] [Related]
10. Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. McColl SR, Staykova MA, Wozniak A, Fordham S, Bruce J, Willenborg DO. J Immunol; 1998 Dec 01; 161(11):6421-6. PubMed ID: 9834134 [Abstract] [Full Text] [Related]
11. Dopamine, serotonin and noradrenaline changes in the striatum of C57BL mice following myelin oligodendrocyte glycoprotein (MOG) 35-55 and complete Freund adjuvant (CFA) administration. Bałkowiec-Iskra E, Kurkowska-Jastrzebska I, Joniec I, Ciesielska A, Członkowska A, Członkowski A. Acta Neurobiol Exp (Wars); 2007 Dec 01; 67(4):379-88. PubMed ID: 18320716 [Abstract] [Full Text] [Related]
12. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Olechowski CJ, Truong JJ, Kerr BJ. Pain; 2009 Jan 01; 141(1-2):156-64. PubMed ID: 19084337 [Abstract] [Full Text] [Related]
13. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Carter SL, Müller M, Manders PM, Campbell IL. Glia; 2007 Dec 01; 55(16):1728-39. PubMed ID: 17902170 [Abstract] [Full Text] [Related]
14. Targeting CB(2) receptor as a neuroinflammatory modulator in experimental autoimmune encephalomyelitis. Lou ZY, Chen C, He Q, Zhao CB, Xiao BG. Mol Immunol; 2011 Dec 01; 49(3):453-61. PubMed ID: 22024414 [Abstract] [Full Text] [Related]
15. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats. Milicevic I, Pekovic S, Subasic S, Mostarica-Stojkovic M, Stosic-Grujicic S, Medic-Mijacevic L, Pejanovic V, Rakic L, Stojiljkovic M. J Neurosci Res; 2003 Apr 15; 72(2):268-78. PubMed ID: 12672002 [Abstract] [Full Text] [Related]
16. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis. Xiao BG, Ma CG, Xu LY, Link H, Lu CZ. Mol Immunol; 2008 Feb 15; 45(4):1191-6. PubMed ID: 17697713 [Abstract] [Full Text] [Related]